
Opinion|Videos|August 6, 2024
Therapies Beyond BCG: FDA-Approved and Emerging Options
Experts discuss available therapies beyond BCG.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- For patients who are either unable to receive BCG therapy, or BCG unresponsive, what other therapeutic options are currently available?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Team-based AE protocols improve consistency with the gemcitabine intravesical therapy system
2
Practical tips for AE management with the gemcitabine intravesical system
3
Jamie Michael, MD, discusses MRI and genomics in active surveillance
4
Richard Schlussel, MD, highlights emerging technologies in pediatric urology
5












